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Sexual health is essential to an individual’s general 
health, affecting quality of life and psychosocial 
and emotional wellbeing; however, sexual problems 
are estimated to affect 40 - 45% of women and 
20 - 30% of men, with the prevalence increasing 
as individuals grow older.[1] A global study of sexual attitudes and 
behaviours, targeting an adult population aged 40 - 80 years across 29 
countries, identified early ejaculation and difficulty in achieving and 
maintaining an erection as the problems most commonly reported 
by men, affecting 24% and 17%, respectively.[2] Lack of sexual interest 
and inability to reach orgasm were the most commonly reported 
complaints for women, affecting 32% and 25%, respectively.[2] 
Diabetes mellitus, cardiovascular disease, genitourinary disease, 
psychiatric or psychological disorders, and poor general health 
have been identified as common comorbid conditions associated 
with sexual dysfunction in both sexes.[1] However, despite the high 
prevalence of sexual problems and comorbidity with commonly 
presenting diseases and disorders, <20% of people experiencing 
sexual difficulties seek assistance from healthcare providers and only 
9% report being asked about their sexual health by their healthcare 
practitioner.[1]
The International Classification of Diseases and Related Health 
Problems (ICD) is in the process of being revised by the World Health 
Organization (WHO), with publication of the ICD-11 planned for 
2017. The WHO has identified improved clinical utility as a key goal 
during this revision process, with an emphasis on improving the 
usefulness of revised classifications for patient case conceptualisation, 
communication, and decision-making with respect to treatment and 
case management.[3] An essential element of the ICD revision process 
has been formative and evaluative field-testing. Formative field-testing 
provided feedback about the basic structure and content of the ICD 
and included a global survey of the opinions of 4  887 psychiatrists.[4] 
Results of this survey indicated that psychiatrists considered the sexual 
dysfunction (F52) disorders of the ICD-10 as having low ease of 
use and poor goodness of fit, suggesting the need for considerable 
revision in the ICD-11 to improve clinical utility.
Background. The World Health Organization is in the process of revising the International Classification of Diseases and Related Health 
Problems (ICD). Sexual dysfunction disorders (F52) have been identified as having poor clinical utility. South Africa (SA) has been selected 
as one of five low- and middle-income countries in which studies will be developed to assess the clinical utility of the proposed ICD-11 
revisions for sexual dysfunction disorders.
Objective. To identify scientific research generated in SA on sexual dysfunction disorders to guide these studies.
Methods. A systematic review of SA research on sexual dysfunction disorders published in peer-reviewed journals.
Results. Despite the high prevalence of ejaculatory and erectile dysfunctions, only five SA articles have addressed male sexual dysfunction 
since 1970. Lack of sexual interest and inability to reach orgasm are the most commonly reported complaints for women, yet only four SA 
articles have been published on the topic of female sexual dysfunction. Diabetes mellitus, cardiovascular disease, genitourinary disease and 
psychiatric or psychological disorders are common comorbid conditions associated with sexual dysfunction in both sexes, but only nine 
articles address sexual dysfunction as the main topic with respect to comorbid conditions.
Conclusion. Despite growing awareness of the importance of sexual health, SA-based scientific research on sexual dysfunction is limited. Further 
work is needed to inform recommendations for ICD-11 revisions drawn from the SA context.
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Sexual dysfunction is currently defined by the ICD-10 as ‘various 
ways in which an individual is unable to participate in a sexual 
relationship as he or she would wish. There may be lack of interest, 
lack of enjoyment, failure of the physiological responses necessary 
for effective sexual interaction, or inability to control or experience 
orgasm’.[5] Sexual dysfunction disorders include sexual desire 
disorders, orgasmic dysfunction and sexual pain disorders in both 
sexes, as well as sexual arousal disorders in women and erectile 
dysfunction (ED) in men. Through an extensive review process, the 
WHO-appointed Working Group on the Classification of Sexual 
Disorders and Sexual Health has compiled suggested revisions 
for this category that are now ready for evaluative field-testing. 
However, in accordance with the recommendations made by the 
International Advisory Group for the Revision of the ICD-10 Mental 
and Behavioural Disorders,[3] all revisions must also be considered for 
cultural sensitivity, relevance and appropriateness. As a result, South 
Africa (SA) has been selected as one of five low- and middle-income 
countries in which country-based field studies will be developed 
to assess the clinical utility of the proposed ICD-11 revisions for 
sexual disorders and sexual health, including sexual dysfunctions. 
In developing these studies, it is important to consider the scientific 
research on sexual dysfunction generated by SA clinicians drawing 
from SA population samples.
Methods
Original research articles published in English on the topic of sexual 
dysfunction were systematically identified using PubMed, Science 
Direct and EBSCOhost (including Academic Search Premier, Africa-
Wide Information, eBook Collection), Health Source: Nursing/
Academic Edition, MasterFILE premier, MEDLINE, PsycARTICLES, 
PsycINFO and SocINDEX databases. Search terms included: ‘sexual 
dysfunct*’ and ‘South Afric*’. Seventeen original research articles met 
the search criteria.
Results
Of the 17 articles included in this review, eight were published in 
international journals that included general medical journals (n=1), 
specialist medical journals (n=6) and non-medical journals (n=1).[6-13] 
Nine were published in SA journals, eight in general medical journals 
(the South African Medical Journal (SAMJ) (n=6) and South African 
Family Practice (SAFP) (n=2)) and one in a specialist medical journal 
(the South African Journal of Psychiatry (SAJP)).[14-22] The first article 
was published in the SAMJ in 1976, while the most recent publication 
appeared in SAFP in 2013. These articles are summarised in Table 1.
Description of the studies
Male sexual dysfunction was first addressed in a case series that 
investigated the use of clomipramine in the treatment of retrograde 
ejaculation following diabetic neuropathy and damage to the bladder 
neck.[14] Treatment was effective in 2/3 of cases.
Next a case report documented the treatment of hypogonado-
trophic hypogonadism as a result of haemochromatosis, with oral 
testosterone.[9]
Over 15 years later, the substitution of phentolamine with 
chlorpromazine as an alpha-blocker in vasoactive cocktails for 
intracavernous injection therapy to treat ED was investigated.[15] 
Results indicated that 96% (n=364) of patients were satisfied with the 
new treatment, with no significant side-effects reported.
More recently, the prevalence of anxiety and depressive symptoms 
in 100 men presenting for the treatment of ED was investigated using 
observational analysis and psychometric measures.[16] ED was severe 
in 57 men, moderate in 36 and mild in 7, while 60 reported premature 
ejaculation. Of the total sample, 41 patients were hypertensive, 
while 42 met the criteria for a psychiatric disorder, 33 reported 
depressive symptoms and 21 met the criteria for an anxiety disorder. 
Men suffering from ED were likely to also suffer from a psychiatric 
disorder and/or an accompanying general medical condition, with 
the probability increasing with severity of ED.
Most recently the prevalence of ED in a sample of 803 men 
attending a primary healthcare clinic in Durban, KwaZulu-Natal, 
was investigated.[17] Results indicated that 64.9% (n=621) of the 
sample had ED, severe in 30.4% (n=244) of cases,  moderate in 19.9% 
(n=160), and mild in 14.6% (n=117). ED increased with age, was 
associated with diabetes, hypertension, cardiovascular disease and 
depression, and was inversely correlated with economic status.
The first SA article addressing female sexual dysfunction 
investigated the efficacy of a psychoeducation intervention 
programme for patients presenting with female orgasmic disorder 
at a family planning clinic.[18] The three-stage intervention began 
with a history-taking session. Based on this information the patient 
was given a diagnosis of primary (having never experienced orgasm) 
or secondary (currently unable to experience orgasm) frigidity. For 
primary frigidity, masturbation and fantasy were recommended, 
while education about clitoral stimulation and different sexual 
positions was provided for patients with secondary frigidity. Reading 
material was also recommended to the couple. The second stage 
of intervention involved a follow-up session with the husband to 
elicit a medical and social history and to provide psychoeducation 
about the positive impact romance, dating and couple-time could 
have on the sexual relationship. The third and final stage involved a 
follow-up session with the female patient to assess whether she had 
achieved orgasm as a result of the intervention and to address any 
remaining problems. Thirty-four couples participated in the study, and 
18 female patients (53%) reported successful orgasm at termination of 
the intervention, 8 (24%) reported significant sexual arousal without 
orgasm, and 8 (24%) reported little or no arousal.
Ten years later, a case study was published on the successful 
treatment of a female patient (aged 25 years) presenting with 
vaginismus without physical cause.[19] A psychoeducational 
intervention focused on reducing the female patient’s anxiety about 
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sexual penetration and gentle desensitisation through relaxation 
exercises, education about her genitalia, practising the use of her 
pubococcygeal muscles to gain a sense of control over her body, 
and practising penetration of her vagina with her fingers, then 
her husband’s fingers and finally with his penis, culminating in 
intercourse. The joint willingness of the patient and her husband to 
commit to the therapy process was identified as a significant factor in 
the successful treatment outcome.
More recently, a pharmacotherapy trial investigated the use of 
granisetron to treat sexual dysfunction associated with antidepressant 
use in female patients diagnosed with depression.[7] Sexual functioning 
was assessed at baseline, day 7 and day 14 using psychometric 
measures. Results indicated no significant treatment effect.
Most recently, a pharmacotherapy trial investigated the use of oral 
sildenafil for the treatment of female sexual arousal disorder as a result 
of spinal cord injury in a sample of 52 women (North America n=23, 
Europe n=23, Australia n=4, South Africa n=2).[8] Sexual functioning 
was monitored using an activity log and psychometric measures. 
Participants were assessed at baseline and during the 12-week treatment 
period. Results indicated no significant treatment effect.[8]
Studies that considered both male and female sexual dysfunction 
included an investigation into the psychosexual factors impacting 
on sexual dysfunction and their related link with infertility in 
a sample of 514 couples.[20,21] Structured interviews generated 
information about the patients’ sexual history, family background 
and relationship history. Analysis of responses revealed that a 
lack of sex education (81% of men and 56% of women), negative 
premarital sex experiences (70.5% of men and 56% of women) 
and infertility (27% of men and 43% of women) were the most 
significant psychosexual problems affecting couples presenting with 
infertility problems, while reduced sexual interest (lack of interest 
in having sex more than once a week) was reported by 68.7% of 
men and dyspareunia was reported by 50% of women. The study 
concluded that inadequate sex education and negative premarital 
sexual and masturbation experiences were the most significant 
contributors to unhelpful attitudes about sexual behaviour. The 
high prevalence of psychosexual problems in this SA sample 
highlighted the need for improved sex education for patients and 
improved training of medical students in sex counselling.
Shortly afterwards, a study aimed to investigate the sexual 
functioning of couples with primary infertility. The study investigated 
the influence on sexual functioning of being instructed to have 
sexual intercourse over the fertile period of the menstrual cycle. [22] 
Couples answered questions relating to frequency of intercourse 
and orgasm, desire and arousal, libido, pain and sexual satisfaction, 
assessed on a self-rating Likert scale, across fertile and non-fertile 
phases of the cycle. Results indicated that 50% of female patients, 
as opposed to only 30% of male patients, reported increased sexual 
dysfunction during this fertile period, with loss of libido being the 
most commonly reported symptom in both sexes.
More recently, a pharmacotherapy cross-over trial investigated 
the use of granisetron 1 mg and sumatriptan 100 mg to treat 
sexual dysfunction associated with serotonergic antidepressant use 
in male and female patients diagnosed with depression.[6] The trial 
included 35 patients who administered the medications 1 hour before 
intercourse. Sexual functioning was assessed using psychometric 
measures. Despite a high dropout rate, granisetron demonstrated a 
significant effect on sexual functioning while sumatriptan showed no 
significant effect.
Additional studies have included investigations of the impact of 
zinc,[11] lead[12] and DDT[13] on sexual functioning. Hydrochloro-
thiazide used for the treatment of hypertension in a sample of 39 middle-
aged men significantly decreased serum zinc levels. These low serum 
zinc levels were associated with sexual dysfunction in the sample.[11] 
Lead exposure was associated with an increased risk of abnormal 
sperm morphology in a sample of 97 lead-exposed workers from an 
hSA lead battery acid factory, but did not demonstrate a significant 
relationship with sperm count or infertility.[12] No strong evidence 
for an association between DDT exposure and semen count, fertility 
and sexual functioning was found in a sample of 60 malaria vector-
control workers in Limpopo Province.[13]
One final contribution to the SA sexual dysfunction literature is 
a case presentation of a 42-year-old man presenting with a history 
of depression, hypersexuality and preoccupation with internet 
pornography, which was used to propose diagnostic criteria for 
hypersexual disorder.[10]
Discussion
Despite the high prevalence of ejaculatory and erectile dysfunctions 
reported in the international literature,[2] only five SA articles[9,14-17] 
have addressed the topic of male sexual dysfunction since 1970, 
with an exclusive focus on ED. Lack of sexual interest and inability 
to reach orgasm are the most commonly reported complaints for 
women,[2] yet only four SA articles[7,8,18,19] have been published on the 
topic of female sexual dysfunction. Diabetes mellitus, cardiovascular 
disease, genitourinary disease and psychiatric or psychological 
disorders are common comorbid conditions associated with sexual 
dysfunction in both sexes;[1] however, only nine articles address 
sexual dysfunction as the main topic with respect to comorbid 
conditions. SA research to date has focused on sexual dysfunction 
and diabetes,[14] haemochromatosis,[9] infertility,[20-22] spinal cord 
injury[8] and psychiatric conditions.[6,7,16,20,21]
Limitations of this review include that it is based only on articles 
published in English in peer-reviewed journals that have been 
electronically indexed. Nevertheless, it probably covers the most 
rigorous research that has been conducted in this area.
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Conclusion
SA-based scientific research on sexual dysfunction is limited and 
outdated, impeding credible recommendations for ICD-11 revisions 
drawn from the SA context. Yet SA is uniquely positioned to make 
a valuable contribution towards the field of sexual health. First, 
given its focus on human rights, SA is well placed to recognise 
sexual health as an important component of health. Recognition of 
the rights and needs of the lesbian, gay, bisexual, transgender and 
intersex communities in the low- and middle-income world is a 
key issue that continues to receive little attention in the literature. 
Second, sexual dysfunction demonstrates high comorbidity with 
HIV infection, and sub-Saharan Africa continues to experience 
a very high prevalence of HIV infections, with 1/20 individuals 
infected, accounting for 69% of people living with HIV globally.[23] Yet 
the impact of HIV/AIDS and other sexually transmitted infections on 
sexual dysfunction in the SA context remains an unexplored area, as 
does the influence of interpersonal violence and intimate partner 
violence on sexual health and functioning. Domestic violence 
has been identified as a considerable contributor to the burden 
of disease in SA, and high rates of sexual and domestic violence 
significantly contribute to the increased vulnerability of SA women 
to sexually transmitted diseases and HIV infection.[24] However, 
limited SA research is currently available to guide clinicians on 
interventions that address both biomedical and psychosocial aspects 
of patients’ sexual dysfunction.
The WHO-funded SA studies will provide an opportunity 
to generate preliminary research in this neglected area, and 
hopefully provide an impetus towards future research. Clinicians 
who wish to participate in these studies can register on the 
WHO Global Practice Network for sexual health practitioners
(http://kuclas.qualtrics.com/SE/?SID=SV_a4SlSQUBNKvVtLn).
Acknowledgements. Prof. Stein is supported by the Medical Research 
Council of South Africa. We thank Dr Geoffrey Reed for his inputs during 
the review of this manuscript.
References
1. Lewis R, Fugl-Meyer KS, Bosch R, et al. Epidemiology/risk factors of sexual dysfunction. J Sex Med
2004;1(1):35-39. [http://dx.doi.org/10.1111/j.1743-6109.2004.10106.x]
2. Moreira E, Brock G, Glasser D, et al. Help-seeking behaviour for sexual problems: The Global Study of Sexual 
Attitudes and Behaviors. Int J Clin Pract 2005;59(1):6-16. [http://dx.doi.org/10.1111/j.1742-1241.2005.00382.x]
3. International Advisory Group for the Revision of ICD-10 Mental and Behavioural Disorders. A conceptual
framework for the revision of the ICD-10 classification of mental and behavioural disorders. World Psychiatry 
2011;10(2):86-92.
4. Reed G, Correia J, Esparza P, Saxena S, Maj M. The WPA-WHO global survey of psychiatrists’ attitudes towards 
mental disorders classification. World Psychiatry 2011;10(2):118-131.
5. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Diagnostic
Criteria for Research. Geneva: WHO, 1993. http://www.who.int/classifications/icd/en/GRNBOOK.pdf
(accessed 24 March 2014).
6. Berk M, Stein DJ, Potgieter A, et al. Serotonergic targets in the treatment of antidepressant induced sexual 
dysfunction: a pilot study of granisetron and sumatriptan. Int Clin Psychopharmacol 2000;15(5):291-295. 
[http://dx.doi.org/10.1097/00004850-200015050-00006]
7. Jespersen S, Berk M, Van Wyk C, et al. A pilot randomized, double-blind, placebo-controlled study of
granisetron in the treatment of sexual dysfunction in women associated with antidepressant use. Int Clin
Psychopharmacol 2004;19(3):161-164. [http://dx.doi.org/10.1097/00004850-200405000-00007]
8. Alexander MS, Rosen RC, Steinberg S, Symonds T, Haughie S, Hultling C. Sildenafil in women with sexual 
arousal disorder following spinal cord injury. Spinal Cord 2011;49(2):273-279. [http://dx.doi.org/10.1038/
sc.2010.107]
9. Stopforth HB, Heyns CF, De Kock MLS, Sandler M. Ejaculatory failure and hypogonadotrophic hypogonadism 
caused by haemochromatosis. BJU Int 1999;83(6):728. [http://dx.doi.org/10.1046/j.1464-410x.1999.00064.x]
10. Stein D, Black DW, Shapira NA, Spitzer RL. Hypersexual disorder and preoccupation with internet
pornography. Am J Psychiatry 2001;158(10):1590-1594. [http://dx.doi.org/10.1176/appi.ajp.158.10.1590]
11. Khedun SM, Naicker T, Maharaj B. Zinc, hydrochlorothiazide and sexual dysfunction. Cent Afr J Med
1995;41(10):312-315.
12. Robins TG, Bornman MS, Ehrlich RI, et al. Semen quality and fertility of men employed in a South
African lead acid battery plant. Am J Ind Med 1997;32(4):369-376. [http://dx.doi.org/10.1002/(SICI)1097-
0274(199710)32:4%3C369::AID-AJIM8%3E3.0.CO;2-P]
13. Dalvie MA, Myers JE, Thompson ML, et al. The long-term effects of DDT exposure on semen, fertility,
and sexual function of malaria vector-control workers in Limpopo Province, South Africa. Environ Res
2004;96(1):1-8. [http://dx.doi.org/10.1016/j.envres.2003.09.002]
14. Eppel S, Berzin M. Pregnancy following treatment of retrograde ejaculation with clomipramine hydrochloride. 
S Afr Med J 1984;66(23):889-891.
15. Uebel R, Schmidt, A. The substitution of phentolamine with an equal amount of chlorpromazine as an
alpha-blocker in vasoactive cocktails used for intracavernous injection therapy for the treatment of erectile 
dysfunction. S Afr Fam Pract 2007;49(1):14.
16. Pankhurst K, Joubert G, Pretorius, P. Prevalence of anxiety and depressive symptoms in men with erectile 
dysfunction. South African Journal of Psychiatry 2008;11(2):57-62.
17. Lockhat Y, Ross A, Ramlachan P, Rangiah C. The prevalence of erectile dysfunction at a primary healthcare
clinic in Durban, KwaZulu Natal. S Afr Fam Pract 2013;55(3):289-293.
18. Michaelides B. Treatment of frigidity in general practice. S Afr Med J 1976;50(34):1337-1339. [http://dx.doi.
org/10.1097/00006254-197703000-00021]
19. Krige P. Vaginismus: A case report. S Afr Med J 1985;67(26):1057-1059.
20. Van Zyl J. Sex and infertility: Part I. Prevalence of psychosexual problems and subjacent factors. S Afr Med J 
1987;72(7):482-484.
21. Van Zyl J. Sex and infertility: Part II. Influence of psychogenic factors and psychosexual problems. S Afr Med
J 1987;72(7):485-487.
22. Hurwitz, M. Sexual dysfunction associated with infertility. A comparison of sexual function during the fertile
and the non-fertile phase of the menstrual cycle. S Afr Med J 1989;76(2):58-61.
23. UNAIDS. Global Report: UNAIDS Report on the Global AIDS Epidemic 2012. Geneva: World Health
Organization, 2012. http://www.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2012/
gr2012/20121120_UNAIDS_Global_Report_2012_with_annexes_en.pdf (accessed 24 March 2104).
24. Dunkle K, Jewkes R. Effective HIV prevention requires gender-transformative work with men. Sex Transm 
Infect 2007;83(3):173-174. [http://dx.doi.org/10.1136/sti.2007.024950]
Accepted 7 January 2014.
IB CME island.indd   1 2014/05/09   8:39 AM
